The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification.
BACKGROUND
The relative incidence of malignant lymphoma subtypes differs according to geographic location. This study investigated the epidemiology of cutaneous lymphoma subtypes in Japan and compared it with other countries.


METHODS
Sixty-two patients with cutaneous lymphoma attending the Department of Dermatology, National Hospital Organization Hokkaido Cancer Center were reviewed. The World Health Organization classification of hematopoietic and lymphoid malignancies was adopted.


RESULTS
Of the 62 patients, 31 had primary cutaneous lymphoma (PCL) and 31 had secondary cutaneous lymphoma (SCL). T- and natural killer (NK)-cell lymphoma accounted for 80% of PCL, of which, mycosis fungoides accounted for almost 35%. Of the 31 patients with secondary cutaneous lymphoma, 17 patients (54%) had T- and NK-cell lymphoma, including nine adult T-cell leukemia/lymphoma patients, and 14 patients (46%) had B-cell lymphoma, including 11 diffuse large B-cell lymphoma patients. The majority of patients with SCL and NK-cell lymphoma with primary or secondary skin lesions had a poor outcome.


CONCLUSIONS
PCL in this study showed a similar incidence to that of other institutions in Japan, while also demonstrating different frequencies from that of other countries, suggesting that the relative frequency of different PCL subtypes differ according to geographical location, similar to previous reports of systemic malignant lymphoma.
Yasukawa
Kana
K
Department of Dermatology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan. kanay@med.hokudai.ac.jp
Kato
Naoko
N
Kodama
Kazuo
K
Hamasaka
Asuka
A
Hata
Hiroo
H
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D015994:Incidence; D007564:Japan / Q000453:epidemiology; D007694:Killer Cells, Natural / Q000473:pathology; D015458:Leukemia, T-Cell / Q000145:classification / Q000453:epidemiology / Q000473:pathology; D008223:Lymphoma / Q000145:classification / Q000453:epidemiology* / Q000473:pathology; D016393:Lymphoma, B-Cell / Q000145:classification / Q000453:epidemiology / Q000473:pathology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000145:classification / Q000453:epidemiology / Q000473:pathology; D016410:Lymphoma, T-Cell, Cutaneous / Q000145:classification / Q000453:epidemiology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000145:classification / Q000453:epidemiology / Q000473:pathology; D012189:Retrospective Studies; D012751:Sezary Syndrome / Q000145:classification / Q000453:epidemiology / Q000473:pathology; D012878:Skin Neoplasms / Q000145:classification / Q000453:epidemiology* / Q000473:pathology; D014944:World Health Organization